Pradžia › Hemofilija
Hemofilija klinikiniai tyrimai JAV ieško dalyvių
28 tyrimai dėl Hemofilija ieško dalyvių vietose visoje Jungtinėse Valstijose.
Miestai su daugiausia tyrimų
- Indianapolis, IN9 tyrimai
- Los Angeles, CA7 tyrimai
- Seattle, WA6 tyrimai
- Cedar Rapids, IA6 tyrimai
- Philadelphia, PA5 tyrimai
- Sacramento, CA4 tyrimai
- Tampa, FL4 tyrimai
- Atlanta, GA4 tyrimai
- Little Rock, AR4 tyrimai
- Dallas, TX4 tyrimai
- Greenville, NC4 tyrimai
- Orange, CA4 tyrimai
- San Francisco, CA3 tyrimai
- San Antonio, TX3 tyrimai
- St. Louis, MO3 tyrimai
- Detroit, MI3 tyrimai
- Boston, MA3 tyrimai
- Cincinnati, OH3 tyrimai
- Chicago, IL3 tyrimai
- Harrisburg, PA3 tyrimai
- Kansas City, MO3 tyrimai
- Aurora, CO3 tyrimai
Pagal valstiją
- Ajova6 tyrimai
- Arkansas4 tyrimai
- Džordžija4 tyrimai
- Florida6 tyrimai
- Ilinoisas4 tyrimai
- Indianas9 tyrimai
- Kalifornija14 tyrimai
- Koloradas3 tyrimai
- Masčusetsas3 tyrimai
- Misūris5 tyrimai
- Mičiganas5 tyrimai
- New York4 tyrimai
- North Carolina6 tyrimai
- Ohio5 tyrimai
- Pennsylvania6 tyrimai
- Texas8 tyrimai
- Washington6 tyrimai
Nesenai atnaujinti tyrimai
Oficialus tyrimo tekstas (anglų kalba)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-10-02 · NCT05568719TG-INSIGHT With Joint POCUS, Hemostatic Potential in Patients With Severe Hemophilia A on Novel Replacement and Substitution FVIII Therapies
Renkami dalyviaiStebimasis tyrimas
6 Months · Visoms lytims · Atnaujinta 2026-09-29 · NCT07692217Treatment of Hemophilia A Patients With FVIII Inhibitors
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Vyrams · Atnaujinta 2026-09-23 · NCT04023019A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-23 · NCT07416526A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Renkami dalyviai3 fazė
Amžius nuo 1 iki 17 · Vyrams · Atnaujinta 2026-09-23 · NCT05611801A Study to Test a Medicine (Fitusiran) for Preventing Bleeds in People With Severe Hemophilia Who Previously Received Preventive Treatment With Emicizumab
Renkami dalyviai4 fazė
Amžius 12 ir vyresni · Vyrams · Atnaujinta 2026-09-23 · NCT06145373A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 64 · Vyrams · Atnaujinta 2026-09-18 · NCT07220564A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of NXT007 in Persons With Severe or Moderate Hemophilia A
Renkami dalyviai1/2 fazė
Amžius nuo 2 iki 59 · Vyrams · Atnaujinta 2026-09-11 · NCT05987449A Gene Therapy Study of SPK-8011QQ in Adults With Severe or Moderately Severe Hemophilia A
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-09-11 · NCT07226206A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Renkami dalyviai3 fazė
Amžius 12 ir vyresni · Visoms lytims · Atnaujinta 2026-09-04 · NCT07416604SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis
Renkami dalyviai3 fazė
Amžius 6 ir vyresni · Visoms lytims · Atnaujinta 2026-08-21 · NCT04563520Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Amžius nuo 0 iki 20 · Visoms lytims · Atnaujinta 2026-08-21 · NCT04278404ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628A Study to Investigate the Efficacy and Safety of Fitusiran Prophylaxis in Male Participants Aged 1 to Less Than 12 Years With Hemophilia A or B
Renkami dalyviai3 fazė
Amžius nuo 1 iki 11 · Vyrams · Atnaujinta 2026-08-17 · NCT07285460Prevention of Bleeding in Patients With Moderate and Severe Hemophilia A Playing Sports: A Comparison Between Factor VIII and Emicizumab Prophylaxis
Renkami dalyviaiStebimasis tyrimas
Amžius nuo 6 iki 19 · Visoms lytims · Atnaujinta 2026-07-02 · NCT05022459A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-07-02 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Renkami dalyviai3 fazė
Amžius nuo 1 iki 74 · Vyrams · Atnaujinta 2026-07-01 · NCT05145127A Study to Learn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.
Renkami dalyviai1 fazė
Amžius nuo 12 iki 74 · Vyrams · Atnaujinta 2026-06-03 · NCT06703606Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-06-02 · NCT03695978Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for Surgery
Renkami dalyviai4 fazė
Amžius 12 ir vyresni · Moterims · Atnaujinta 2026-05-12 · NCT05936580Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis Study
Renkami dalyviai4 fazė
Amžius 12 ir vyresni · Vyrams · Atnaujinta 2026-05-12 · NCT05935358ATHNdataset Registry
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-04-21 · NCT06820515Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Renkami dalyviai1 fazė
Amžius nuo 0 iki 90 · Visoms lytims · Atnaujinta 2026-04-03 · NCT05500807Hemophilia A Research Program
Renkami dalyviaiStebimasis tyrimasLaukiami sveiki savanoriai
Visi amžiai · Visoms lytims · Atnaujinta 2026-02-17 · NCT07414511SEVENFACT® for Bleeding Events in Hemophilia With Inhibitors
Renkami dalyviai4 fazė
Amžius nuo 12 iki 100 · Visoms lytims · Atnaujinta 2026-01-12 · NCT04647227Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.